IVDs For Presence of Biothreats Should Evaluate Animal Specimens - FDA
This article was originally published in The Gray Sheet
Executive Summary
Developers of in vitro diagnostic tests for identification of biothreat agents should evaluate animal specimens and spiked plasma when seeking FDA approval, according to FDA's Microbiology Devices Panel.